Other Science

476 articles

Page
November 13, 2024 • 3 Min

Pancreatic Neuroendocrine Tumors (PNET)

Learn the Basics Getting diagnosed with pancreatic cancer is overwhelming. Besides not feeling well, you are thrown into a world with treatments, procedures, and words you don’t know, while facing major decisions and a very serious disease. Here you can find comprehensive explanations, including different treatments and questions to ask. To learn more about first […]

Research
October 12, 2017 • 5 Min

Tumor Genetics Research Brings Some Answers for Families at High Risk

Professor Gloria Peterson of the Mayo Clinic is working on tumor genetics to help make early detection of pancreatic cancer a reality.

Research
January 16, 2018 • 3 Min

Neoantigens Provide New Hope for Pancreatic Cancer Treatments

Vinod Balachandran’s team identified increased T cells in the tumors of long-term pancreatic cancer survivors, with a role for neoantigens in immunotherapy.

Research
May 1, 2018 • 3 Min

Collaborative Multi-Center Immunotherapy Trial Targets CD40 and PD-1

Dr. Mark O’Hara outlines a collaborative clinical trial of two immunotherapy agents–a checkpoint inhibitor and a monoclonal antibody–plus standard chemotherapy.

Research
June 21, 2018 • 3 Min

Multicenter Trial Focuses on Neoadjuvant Treatment for Borderline Resectable and Locally Advanced Disease

Dr. David Ryan outlines a new trial for pre-surgical pancreatic cancer treatment combining a blood pressure drug, immunotherapy, standard care and SBRT.

Research
July 31, 2018 • 4 Min

A Combination of Neoadjuvant Chemotherapy and Radiation Shows Promise

Dr. Alok Khorana discusses the results of clinical trials of neoadjuvant chemotherapy and radiation to make surgery more effective.

Research
August 24, 2018 • 5 Min

New Research Sheds Light on Hot and Cold Tumors

Dr. Ben Z. Stanger and his team are finding links between the number of T cells a tumor has and the effectiveness of immunotherapy.

Research
September 12, 2018 • 3 Min

Tough Tortoise of a Drug Beating Metastatic Pancreatic Cancer

Rexahn Pharmaceuticals is testing RX-3117, a slow-releasing drug similar to gemcitabine, in a clinical trial for metastatic pancreatic cancer patients.

Survivor Stories
January 24, 2024 • 4 Min

Don’t Give Up

Joe Pearson responded so well to chemotherapy that even with a stage III tumor near a blood vessel he was able to have Whipple surgery.

Survivor Stories
October 20, 2023 • 4 Min

A New Radiation Therapy Helped Me Beat Cancer

Connie Harrington’s tumor was wrapped around an artery, eliminating surgery. After chemo, her oncologist steered her to MRI-guided radiation, which has made all the difference.

Disease Management
February 14, 2024 • 5 Min

Nutrition Myths Debunked

Does sugar really feed cancer? Is a keto diet better for cancer? Should cancer patients avoid fats? Dietitians L.J. Amaral and Jessica Harrison take on common nutrition myths.

Survivor Stories
October 9, 2023 • 4 Min

Changing Course Midstream

Barbara Green wasn’t happy with her doctors, so she took the advice of her support group, was an advocate for herself, and changed doctors.

Research
September 21, 2023 • 2 Min

Testing the Addition of a New Drug to Radiation Therapy for Localized Pancreatic Cancer

In combination with radiation treatment, researchers are testing a new drug that causes DNA damage to make that treatment more effective.

Research
August 14, 2023 • 2 Min

Targeting Pancreatic Cancer Cell Growth

Researchers are testing a new drug targeting cell growth in solid tumors, including pancreatic cancer.

Research
July 27, 2023 • 4 Min

New Study Targets Specific BRAF Mutation

One type of BRAF mutation may provide a target for treatment in pancreatic cancer patients, explains Dr. Michael Pishvaian.